This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Maki, A. Articles by Ishikawa, K. Search for Related Content PubMed PubMed Citation Articles by Maki, A. Articles by Ishikawa, K. Social Bookmarking                         What's this?

Mechanism of Rethrombosis After Thrombolytic Therapy: Angioscopic Findings and Investigation of the Coagulation System in Dogs

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Chiaki Shirato, MD

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Masahisa Ohguchi, MD

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Nobuo Aoki, MD

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Nobuhiko Ochiai, PhD

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Shigeru Taguchi, PhD

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Isao Aoki, MD

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Kyozo Ishikawa, MD

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

The purpose of this study was to angioscopically observe the process of thrombolysis after intracoronary administration of thrombolytic agents and to investigate the effects of these agents on coagulation/fibrinolysis systems in dogs. The coronary endothelium was removed and thrombus formation was confirmed by angioscopy. In the tissue plas minogen activator (tPA) group (n=8), complete thrombolysis occurred in all animals, but thrombolysis was incomplete in the urokinase (UK) group (n=6). The plasma level of plasmin 2-plasmin inhibitor complex peaked at 15 minutes after treatment in both the tPA and UK groups. Plasma thrombin-antithrombin III (TAT) complex decreased tran siently at 15 minutes after tPA administration but increased at 30 and 60 minutes (P<0.05). In the UK group, plasma TAT also showed a transient decrease followed by an increase, which was minimal compared with that in the tPA group. Plasma TAT decreased transiently after infusion of tPA and subsequently increased to above the pretreatment level, suggesting a risk of rethrombosis after successful recanalization.

Angiology, Vol. 49, No. 6, 447-453 (1998)
DOI: 10.1177/000331979804900605


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?